Enochian's top scientist treated patients with leeches, mistletoe and B-17
Serhat Gumrukcu, the man behind the possible HIV cure being developed by Enochian Biosciences, was ordered to pay $253,000 in compensation to a family he treated with leeches, mistletoe and the potentially poisonous substance B-17. Worst case, the treatment can be deadly, warns the Danish Cancer Society.
BY KEVIN GRØNNEMANN AND PETER THOMSEN
Scientist Serhat Gumrukcu is the man behind the potential cure for HIV being developed by biotech company Enochian Biosciences and is described by the company's executive vice chairman Mark Dybul as "one of those rare geniuses that is not bound by scientific discipline or dogma."
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
